FindTrial
Sign In

Dose-response relationship of alfentanil combined with propofol in children undergoing painless dermabrasion

Dose-response relationship of alfentanil combined with propofol in children undergoing painless dermabrasion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054787
Enrollment
Unknown
Registered
2021-12-27
Start date
2021-12-29
Completion date
Unknown
Last updated
2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Interventions

Intervention Group:Alfentanil (Dixon sequential method for dose adjustment)

Sponsors

Hangzhou Third People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 10 Years

Inclusion criteria

Inclusion criteria: 1. Selected ASA I-II grade children with vitiligo for elective skin laser abrasion and completed informed consent; 2. Gender is not limited; 3. Age 5-10 years old.

Exclusion criteria

Exclusion criteria: 1. Upper respiratory tract infection within 2 weeks; 2. History of asthma; 3. No fasting and drinking before surgery.

Design outcomes

Primary

MeasureTime frame
Body movement;—

Countries

China

Contacts

Public ContactWang Bo

Hangzhou Third People’s Hospital

qiubajia@163.com+86 15068180821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026